Search Results

There are 11564 results for: content related to: A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

  1. You have free access to this content
    Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer

    Cancer

    Volume 116, Issue 16, 15 August 2010, Pages: 3903–3909, Suresh S. Ramalingam, R. Donald Harvey, Nabil Saba, Taofeek K. Owonikoko, John Kauh, Dong M. Shin, Shi-Yong Sun, Sandra Strychor, Mourad Tighiouart, Merrill J. Egorin, Haian Fu and Fadlo R. Khuri

    Article first published online : 1 JUN 2010, DOI: 10.1002/cncr.25264

  2. You have free access to this content
    A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer

    Cancer

    Volume 119, Issue 10, 15 May 2013, Pages: 1823–1831, Matthew G. Fury, Eric Sherman, Alan L. Ho, Han Xiao, Frank Tsai, Oby Nwankwo, Camelia Sima, Adrian Heguy, Nora Katabi, Sofia Haque and David G. Pfister

    Article first published online : 13 FEB 2013, DOI: 10.1002/cncr.27986

  3. The Therapeutic Potential of mTOR Inhibitors in Breast Cancer

    British Journal of Clinical Pharmacology

    Accepted manuscript online: 5 APR 2016, Linda S. Steelman, Alberto M. Martelli, Lucio Cocco, Massimo Libra, Ferdinando Nicoletti, Stephen L. Abrams and James A. McCubrey

    DOI: 10.1111/bcp.12958

  4. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

    Head & Neck

    Volume 38, Issue S1, April 2016, Pages: E844–E852, Shau-Hsuan Li, Wei-Che Lin, Tai-Lin Huang, Chang-Han Chen, Tai-Jan Chiu, Fu-Min Fang, Wan-Ting Huang, Cheng-Ming Hsu, Sheng-Dean Luo, Chi-Chih Lai, Yan-Ye Su, Hui-Ching Chuang and Chih-Yen Chien

    Article first published online : 18 JUL 2015, DOI: 10.1002/hed.24111

  5. You have free access to this content
    A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option

    International Journal of Cancer

    Volume 136, Issue 12, 15 June 2015, Pages: 2940–2948, Konrad Klinghammer, Jan-Dirk Raguse, Thomas Plath, Andreas E. Albers, Korinna Joehrens, Andre Zakarneh, Bernadette Brzezicha, Annika Wulf-Goldenberg, Ulrich Keilholz, Jens Hoffmann and Iduna Fichtner

    Article first published online : 26 NOV 2014, DOI: 10.1002/ijc.29344

  6. You have free access to this content
    Neoadjuvant systemic therapy for urological malignancies

    BJU International

    Volume 106, Issue 1, July 2010, Pages: 6–22, Guru Sonpavde and Cora N. Sternberg

    Article first published online : 7 JUN 2010, DOI: 10.1111/j.1464-410X.2010.09425.x

  7. You have free access to this content
    Current and emerging targeted therapies for metastatic breast cancer

    Cancer

    Volume 118, Issue 12, 15 June 2012, Pages: 3014–3025, Edith A. Perez and Jean-Philippe Spano

    Article first published online : 17 OCT 2011, DOI: 10.1002/cncr.26356

  8. You have free access to this content
    Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

    Cancer

    Volume 120, Issue 24, December 15, 2014, Pages: 3940–3951, Nabil F. Saba, Selwyn J. Hurwitz, Kelly Magliocca, Sungjin Kim, Taofeek K. Owonikoko, Donald Harvey, Suresh S. Ramalingam, Zhengjia Chen, Jackie Rogerio, Jennifer Mendel, Scott A. Kono, Colleen Lewis, Amy Y. Chen, Kristin Higgins, Mark El-Deiry, Trad Wadsworth, Jonathan J. Beitler, Dong M. Shin, Shi-Yong Sun and Fadlo R. Khuri

    Article first published online : 7 AUG 2014, DOI: 10.1002/cncr.28965

  9. RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid

    The Prostate

    Volume 68, Issue 8, 1 June 2008, Pages: 861–871, Todd M. Morgan, Tiffany E.M. Pitts, Ted S. Gross, Sandra L. Poliachik, Robert L. Vessella and Eva Corey

    Article first published online : 24 MAR 2008, DOI: 10.1002/pros.20752

  10. You have free access to this content
    Mechanisms of Everolimus-Induced Glomerulosclerosis After Glomerular Injury in the Rat

    American Journal of Transplantation

    Volume 5, Issue 12, December 2005, Pages: 2849–2861, C. Daniel, L. Renders, K. Amann, E. Schulze-Lohoff, I.A. Hauser and C. Hugo

    Article first published online : 18 NOV 2005, DOI: 10.1111/j.1600-6143.2005.01120.x

  11. Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Article first published online : 23 OCT 2014, DOI: 10.1111/bju.12867

  12. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

    Liver Transplantation

    Volume 21, Issue 8, August 2015, Pages: 1056–1065, Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas-Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez-Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera and for the EVEROLIVER study group

    Article first published online : 24 JUL 2015, DOI: 10.1002/lt.24172

  13. You have free access to this content
    Role of targeted therapy in the treatment of advanced prostate cancer

    BJU International

    Volume 105, Issue 6, March 2010, Pages: 748–767, Karim Fizazi, Cora N. Sternberg, John M. Fitzpatrick, R. William Watson and Majid Tabesh

    Article first published online : 25 FEB 2010, DOI: 10.1111/j.1464-410X.2010.09236.x

  14. You have full text access to this OnlineOpen article
    Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma

    Cancer Medicine

    Volume 2, Issue 3, June 2013, Pages: 325–333, Dominique Werner, Akin Atmaca, Claudia Pauligk, Anette Pustowka, Elke Jäger and Salah-Eddin Al-Batran

    Article first published online : 2 APR 2013, DOI: 10.1002/cam4.77

  15. Blood Concentrations of Everolimus Are Markedly Increased by Ketoconazole

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 514–528, Dr J. M. Kovarik, Dr D. Beyer, Dr M. N. Bizot, Dr Q. Jiang, Dr M. Shenouda and Dr R. L. Schmouder

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005275368

  16. You have free access to this content
    Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel

    BJU International

    Volume 114, Issue 6b, December 2014, Pages: E11–E17, Philipp Nuhn, Ajay M. Vaghasia, Jatinder Goyal, Xian C. Zhou, Michael A. Carducci, Mario A. Eisenberger and Emmanuel S. Antonarakis

    Article first published online : 14 FEB 2014, DOI: 10.1111/bju.12531

  17. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Article first published online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  18. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Article first published online : 25 MAR 2015, DOI: 10.1111/cas.12647

  19. A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer

    Cancer

    Helen Chow, Paramita M. Ghosh, Ralph deVere White, Christopher P. Evans, Marc A. Dall'Era, Stanley A. Yap, Yueju Li, Laurel A. Beckett, Primo N. Lara Jr and Chong-Xian Pan

    Article first published online : 28 MAR 2016, DOI: 10.1002/cncr.29927

  20. You have free access to this content
    Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1401–1413, H. Tedesco Silva Jr., D. Cibrik, T. Johnston, E. Lackova, K. Mange, C. Panis, R. Walker, Z. Wang, G. Zibari and Y. S. Kim

    Article first published online : 28 APR 2010, DOI: 10.1111/j.1600-6143.2010.03129.x